Industry Discovery & Development Partnership (IDDP) Program
The Breakthrough T1D IDDP Program funds for-profit companies to develop new therapies or devices for type 1 diabetes, supporting projects with strong scientific merit and clear commercialization plans.
Funder: Breakthrough T1D
Due Dates: Rolling (LOIs and applications accepted year-round)
Funding Amounts: No specified limit; project budgets and durations are negotiated per application and require matching funds from the applicant.
Summary: Supports for-profit entities conducting research and development of therapies or devices for type 1 diabetes aligned with Breakthrough T1D’s priorities.
Key Information: Applicants must commit matching funds equal to or greater than the amount requested.
Description
The Industry Discovery & Development Partnership (IDDP) Program provides flexible funding and collaborative support to for-profit organizations—including biotechnology, pharmaceutical, device companies, and other industry entities—for research projects that closely align with Breakthrough T1D’s strategic priorities. The program aims to accelerate the discovery, development, and commercialization of therapeutics and devices for type 1 diabetes (T1D) by leveraging industry strengths and fostering partnerships between the private sector and Breakthrough T1D. Projects must demonstrate a clear path toward meaningful impact for the T1D community and should include a plan for future commercialization.
